Gupta et al., 2012 - Google Patents
MicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapyGupta et al., 2012
View HTML- Document ID
- 5028524719546805462
- Author
- Gupta A
- Swaminathan G
- Martin-Garcia J
- Navas-Martin S
- Publication year
- Publication venue
- Viruses
External Links
Snippet
MicroRNAs (miRNAs) can exert a profound effect on Hepatitis C virus (HCV) replication. The interaction of HCV with the highly liver-enriched miRNA, miR-122 represents one such unique example of viruses having evolved mechanism (s) to usurp the host miRNA …
- 241000711549 Hepacivirus C 0 title abstract description 256
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gupta et al. | MicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapy | |
Kunden et al. | The role of the liver-specific microRNA, miRNA-122 in the HCV replication cycle | |
Khatun et al. | Mechanisms underlying hepatitis C virus-associated hepatic fibrosis | |
Loureiro et al. | miRNAs as potential biomarkers for viral hepatitis B and C | |
Vojtechova et al. | The role of miRNAs in virus-mediated oncogenesis | |
Balasubramaniam et al. | Are microRNAs important players in HIV-1 infection? An update | |
Hayes et al. | MicroRNAs as biomarkers for liver disease and hepatocellular carcinoma | |
Liu et al. | Hepatitis B virus X protein and hepatocarcinogenesis | |
Herengt et al. | NRF2 in viral infection | |
Sarkar et al. | Hepatitis B virus infection, microRNAs and liver disease | |
Ma et al. | Involvement of host non-coding RNAs in the pathogenesis of the influenza virus | |
Piñeiro et al. | RNA structural elements of hepatitis C virus controlling viral RNA translation and the implications for viral pathogenesis | |
Ho et al. | MicroRNA and pathogenesis of enterovirus infection | |
Thirion et al. | Roles of microRNAs in the hepatitis B virus infection and related diseases | |
Pollutri et al. | TP53/MicroRNA interplay in hepatocellular carcinoma | |
Plissonnier et al. | Non-coding RNAs and hepatitis C virus-induced hepatocellular carcinoma | |
Moles et al. | The emerging role of miRNAs in HTLV-1 infection and ATLL pathogenesis | |
Duan et al. | Microrna-130a downregulates HCV replication through an atg5-dependent autophagy pathway | |
Nowak et al. | Argonaute proteins take center stage in cancers | |
Panigrahi et al. | MicroRNA-122 regulation of HCV infections: insights from studies of miR-122-independent replication | |
Bauer et al. | MicroRNAs: small but key players in viral infections and immune responses to viral pathogens | |
Ostrycharz et al. | Micro-players of great significance—host microRNA signature in viral infections in humans and animals | |
Li et al. | Roles of microRNAs in hepatitis C virus replication and pathogenesis | |
Ullmer et al. | Diverse strategies used by picornaviruses to escape host RNA decay pathways | |
Morishita et al. | MicroRNA interference in hepatic host-pathogen interactions |